https://scholars.lib.ntu.edu.tw/handle/123456789/641161
標題: | Correction to: Risk scores to predict HCC and the benefits of antiviral therapy for CHB patients in gray zone of treatment guidelines | 作者: | Teng, Wei Chang, Ting-Tsung Yang, Hwai-I Peng, Cheng-Yuan Su, Chien-Wei TUNG-HUNG SU Hu, Tsung-Hui Yu, Ming-Lung Yang, Hung-Chih Wu, Jaw-Ching |
公開日期: | 22-一月-2024 | 來源出版物: | Hepatology international | 摘要: | Authors would like to add below funding information to their publication. This study was supported by funding from Ministry of Science and Technology (National Science and Technology Council) (104-2314-B-182A-048-MY3; 110-2314-B-A49A-505; 110-2314-B-075-010-MY3), VGHUST Joint Research Program, Tsou Foundation (VGHUST110-G7-3-3), VGHTPE Research Program (V107C-161, V108C-059 and V109C-049), Ministry of Health and Welfare (MOHW107-TDU-B-211-114019; 108-TDU-B-211-124019; 109-TDU-B-211-134019; 110-TDU-B-211-144019) and Cancer Progression Research Center, National Yang-Ming University from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education. The original article has been corrected. |
URI: | https://www.scopus.com/record/display.uri?eid=2-s2.0-85182805291&doi=10.1007%2fs12072-023-10634-6&origin=inward&txGid=006fad16496dd34da3053b9b2126e4f8 https://scholars.lib.ntu.edu.tw/handle/123456789/641161 |
ISSN: | 19360533 | DOI: | 10.1007/s12072-023-10634-6 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。